Literature DB >> 365750

Antibody-independent interaction of the first component of complement with Gram-negative bacteria.

M Loos, B Wellek, R Thesen, W Opferkuch.   

Abstract

The interaction of the first component of complement with two serum-sensitive strains of Escherichia coli and Klebsiella pneumoniae was studied. It could be demonstrated that highly purified C1, free of immunoglobulin G and immunoglobulin M, binds to E. coli or K. pneumoniae. C1 binding was also found with specifically absorbed human serum, after incubation of bacteria with normal serum in the presence of ethylenediaminetetraacetate or agammaglobulinemic serum; the number of C1 molecules taken up by the bacteria was not influenced, indicating that C1 binding was independent of naturally occurring antibodies. C1 bound to bacteria was still able to cleave C4, the natural substrate of C1. From these observations, it is concluded that C1 in an enzymatically active state can be bound directly to bacteria independently of antibody.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 365750      PMCID: PMC422107          DOI: 10.1128/iai.22.1.5-9.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  ACTION OF THE FIRST COMPONENT OF COMPLEMENT. ACTIVITATION OF C'1 TO C'1A IN THE HEMOLYTIC SYSTEM.

Authors:  T BORSOS; H J RAPP; U L WALZ
Journal:  J Immunol       Date:  1964-01       Impact factor: 5.422

2.  Bactericidal and opsonic properties of C4-deficient guinea pig serum.

Authors:  R K Root; L Ellman; M M Frank
Journal:  J Immunol       Date:  1972-09       Impact factor: 5.422

3.  [Studies on the immune bacteriolysis. XIV. Requirement of all nine components of complement for immune bacteriolysis].

Authors:  K Inoue; K Yonemasu; A Takamizawa; T Amano
Journal:  Biken J       Date:  1968-09

4.  Antibody-independent activation of human C1 after interaction with heart subcellular membranes.

Authors:  R N Pinckard; M S Olson; R E Kelley; D H DeHeer; J D Palmer; R A O'Rourke; S Goldfein
Journal:  J Immunol       Date:  1973-05       Impact factor: 5.422

5.  Activation of the first component of complement evidence for an internal activation step.

Authors:  M Loos; T Borsos; H J Rapp
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

6.  [Measurement of complement with a microliter method].

Authors:  R Ringelmann; W Opferkuch; M Röllinghoff; M Loos
Journal:  Z Med Mikrobiol Immunol       Date:  1969

7.  Hemolysin titration based on fixation of the activated first component of complement: evidence that one molecule of hemolysin suffices to sensitize an erythrocyte.

Authors:  T Borsos; H J Rapp
Journal:  J Immunol       Date:  1965-09       Impact factor: 5.422

8.  Purification of the first component of complement by zonal ultracentrifugation.

Authors:  H R Colten; H E Bond; T Borsos; H J Rapp
Journal:  J Immunol       Date:  1969-10       Impact factor: 5.422

9.  Activation of complement by opportunist pathogens and chemotypes of Salmonella minnesota.

Authors:  A B Bjornson; H S Bjornson
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

10.  Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components.

Authors:  H Gewurz; H S Shin; S E Mergenhagen
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

View more
  22 in total

1.  Antibody-independent binding of complement component C1q by Legionella pneumophila.

Authors:  C S Mintz; P I Arnold; W Johnson; D R Schultz
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

2.  Antibody-independent activation of the classical pathway of complement by Epstein-Barr virus.

Authors:  H Martin; I McConnell; B Gorick; N C Hughes-Jones
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

3.  C1q binding and activation of the complement classical pathway by Klebsiella pneumoniae outer membrane proteins.

Authors:  S Albertí; G Marqués; S Camprubí; S Merino; J M Tomás; F Vivanco; V J Benedí
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

4.  Killing of an encapsulated strain of Escherichia coli by human serum.

Authors:  P W Taylor; H P Kroll
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

5.  Electron microscopic study showing antibody-independent binding of C1q, a subcomponent of the first component of complement, to serum-sensitive salmonellae.

Authors:  F Clas; J R Golecki; M Loos
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

6.  Sensitivity of Capnocytophaga species to bactericidal properties of human serum.

Authors:  M E Wilson; R Burstein; J T Jonak-Urbanczyk; R J Genco
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

7.  Antibody-independent interactions of fibronectin, C1q, and human neutrophils with Treponema pallidum.

Authors:  R E Baughn
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

8.  Antibody-independent binding of the first component of complement (C1) and its subcomponent C1q to the S and R forms of Salmonella minnesota.

Authors:  F Clas; M Loos
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

9.  Differential complement resistance mediates virulence of Haemophilus influenzae type b.

Authors:  A Sutton; R Schneerson; S Kendall-Morris; J B Robbins
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

10.  Solid-phase C1q-directed bacterial capture followed by PCR for detection of Chlamydia trachomatis in clinical specimens.

Authors:  P Herbrink; H A van den Munckhof; H G Niesters; W H Goessens; E Stolz; W G Quint
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.